Aslam

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

Embracing the unknown: disentangling the complexities of the soil microbiome

Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease

Posaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other Conditions

Infections due to emerging and uncommon medically important fungal pathogens

The Top 10 fungal pathogens in molecular plant pathology

A review of recent strategies for acid mine drainage prevention and mine tailings recycling

A review of nucleic acid-based diagnostic tests for systemic mycoses with an emphasis on polymerase chain reaction-based assays

Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America

Manganese Toxicity Upon Overexposure: a Decade in Review

Fusarium Infections in Immunocompromised Patients

2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

Agricultural uses of plant biostimulants

Advances in plant growth-promoting bacterial inoculant technology: formulations and practical perspectives (1998–2013)

Pharmacokinetics, Safety, and Efficacy of Posaconazole in Patients with Persistent Febrile Neutropenia or Refractory Invasive Fungal Infection

Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America

Effect of Plant Growth-Promoting Rhizobacteria on Growth, Nodulation and Nutrient Accumulation of Lentil Under Controlled Conditions

Bone manganese as a biomarker of manganese exposure: A feasibility study

The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non‐immunocompromised patients: a single institution experience over 10 years